Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Whiteman

Showing results (1-10 of 476) with videos related to

Pageof 48
Sort By:
Expert Review of Anticancer Therapy|May 18, 2010
Testing the divergent pathway hypothesis for melanoma: recent findings and future challengesDavid C Whiteman
The British Journal of Dermatology|May 7, 2025
Melanoma in England: incidence is up, mortality is downDavid C Whiteman
Australian and New Zealand Journal of Public Health|February 9, 2011
'Blue sky' epidemiology: definition, examples and a plea for understandingDavid C Whiteman
The Lancet. Global Health|May 1, 2020
Regular opium use and subsequent incidence of cancerDavid C Whiteman
The British Journal of Dermatology|September 18, 2025
BRAF testing for melanoma in EnglandDavid C Whiteman
BMJ (Clinical Research Ed.)|March 28, 2009
Hot tea and increased risk of oesophageal cancerDavid C Whiteman
Gut|April 30, 2014
Does a prior diagnosis of Barrett's oesophagus influence risk of dying from oesophageal adenocarcinoma?David C Whiteman
Journal of Gastroenterology and Hepatology|March 30, 2011
Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult communityNirmala Pandeya, David C Whiteman,
Cancer Epidemiology|July 28, 2016
The fractions of cancer attributable to modifiable factors: A global reviewDavid C Whiteman, Louise F Wilson
Cancer Epidemiology|May 7, 2013
Can we really predict risk of cancer?Aaron P Thrift, David C Whiteman
Pageof 48

Showing results (1-10 of 476) with videos related to

Sort By:
Pageof 48
Expert Review of Anticancer Therapy|May 18, 2010
Testing the divergent pathway hypothesis for melanoma: recent findings and future challengesDavid C Whiteman
The British Journal of Dermatology|May 7, 2025
Melanoma in England: incidence is up, mortality is downDavid C Whiteman
Australian and New Zealand Journal of Public Health|February 9, 2011
'Blue sky' epidemiology: definition, examples and a plea for understandingDavid C Whiteman
The Lancet. Global Health|May 1, 2020
Regular opium use and subsequent incidence of cancerDavid C Whiteman
The British Journal of Dermatology|September 18, 2025
BRAF testing for melanoma in EnglandDavid C Whiteman
BMJ (Clinical Research Ed.)|March 28, 2009
Hot tea and increased risk of oesophageal cancerDavid C Whiteman
Gut|April 30, 2014
Does a prior diagnosis of Barrett's oesophagus influence risk of dying from oesophageal adenocarcinoma?David C Whiteman
Journal of Gastroenterology and Hepatology|March 30, 2011
Prevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult communityNirmala Pandeya, David C Whiteman,
Cancer Epidemiology|July 28, 2016
The fractions of cancer attributable to modifiable factors: A global reviewDavid C Whiteman, Louise F Wilson
Cancer Epidemiology|May 7, 2013
Can we really predict risk of cancer?Aaron P Thrift, David C Whiteman
Pageof 48